Skip to main content
SpringerLink
Log in

Volumentherapie

Die Intensivmedizin

Part of the book series: Springer Reference Medizin ((SRM))

  • 478 Accesses

Zusammenfassung

In der Therapie des Schocks und bei der Therapie kritisch kranker Patienten ist der Wert einer schnellen und effektiven Volumentherapie in der Intensivmedizin unumstritten. Durch Erhalt und Wiederherstellung des notwendigen Plasmavolumens verbessert man die Organperfusion und erhält die notwendige Mikrozirkulation. Im Schock besteht sowohl ein absoluter als auch ein relativer Flüssigkeitsmangel mit Abnahme der kardialen Vorlast, konsekutiver Verminderung des Herzzeitvolumens, Reduktion der Mikrozirkulation und somit einer Reduktion der Gewebeoxygenierung. Es muss ein ausreichend zirkulierendes Blutvolumen erreicht werden. Durch diese z. T. sehr umfassende Volumentherapie soll eine Steigerung der Pumpleistung des Herzens und dadurch eine verbesserte Gewebeoxygenierung und Gewebeperfusion sowie eine bessere Organfunktion insgesamt erreicht werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Alderson P, Bunn F, Lefebvre C, Li WP, Li L, Roberts I et al (2004) Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev [Meta-Analysis Review] (4):CD001208

    Google Scholar 

  • Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declère AD et al (2013) Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 310(17):1809–1817

    Article  CAS  PubMed  Google Scholar 

  • Blasco V, Leone M, Antonini F, Geissler A, Albanese J, Martin C (2008) Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth 100(4):504–508

    Article  CAS  PubMed  Google Scholar 

  • Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358(2):125–139

    Article  CAS  PubMed  Google Scholar 

  • Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM et al (2012) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 39(2):165–228

    Article  Google Scholar 

  • Dubin A, Pozo MO, Casabella CA, Murias G, Palizas F Jr, Moseinco MC et al (2010) Comparison of 6 % hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 25(4):659 e1–659 e8

    Article  PubMed  Google Scholar 

  • Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350(22):2247–2256

    Article  CAS  PubMed  Google Scholar 

  • Friedman G, Jankowski S, Shahla M, Gomez J, Vincent JL (2008) Hemodynamic effects of 6 % and 10 % hydroxyethyl starch solutions versus 4 % albumin solution in septic patients. J Clin Anesth 20(7):528–533 [Comparative Study Randomized Controlled Trial]

    Article  CAS  PubMed  Google Scholar 

  • Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P (2008) Safety of HES 130/0.4 (Voluven (R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol 25(12):986–994

    Article  CAS  PubMed  Google Scholar 

  • Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M et al (2013) Hydroxyethyl starch 130/0.38–0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 346:f839

    Article  PubMed Central  PubMed  Google Scholar 

  • Lehmann G, Marx G, Forster H (2007a) Bioequivalence comparison between hydroxyethyl starch 130/0.42/6: 1 and hydroxyethyl starch 130/0.4/9: 1. Drugs RD 8(4):229–240

    Article  CAS  Google Scholar 

  • Lehmann GB, Asskali F, Boll M, Burmeister MA, Marx G, Hilgers R et al (2007b) HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly. Br J Anästh 98(5):635–644

    Article  CAS  Google Scholar 

  • Monnet X, Rienzo M, Osman D, Anguel N, Richard C, Pinsky MR et al (2006) Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med 34(5):1402–1407

    Article  PubMed  Google Scholar 

  • Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, Bishop N et al (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357(9):874–884

    Article  CAS  PubMed  Google Scholar 

  • Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D et al (2012) Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367(20):1901–1911

    Article  CAS  PubMed  Google Scholar 

  • Palumbo D, Servillo G, D’Amato L, Volpe ML, Capogrosso G, De Robertis E et al (2006) The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol 72(7–8):655–664

    CAS  PubMed  Google Scholar 

  • Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A et al (2012) Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367(2):124–134

    Article  CAS  PubMed  Google Scholar 

  • Ring J, Messmer K (1977) Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1(8009):466–469

    Article  CAS  PubMed  Google Scholar 

  • Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–1377

    Article  CAS  PubMed  Google Scholar 

  • Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J et al (2007) Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 98(2):216–224

    Article  CAS  PubMed  Google Scholar 

  • Saw MM, Chandler B, Ho KM (2012) Benefits and risks of using gelatin solution as a plasma expander for perioperative and critically ill patients: a meta-analysis. Anaesth Intensive Care 40(1):17–32

    PubMed  Google Scholar 

  • Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR et al (2012) Major complications, mortality, and resource utilization after open abdominal surgery: 0.9 % saline compared to Plasma-Lyte. Ann Surg 255(5):821–829

    Article  PubMed  Google Scholar 

  • Smith SH, Perner A (2012) Higher vs. lower fluid volume for septic shock: clinical characteristics and outcome in unselected patients in a prospective, multicenter cohort. Crit Care 16(3):R76

    Article  PubMed Central  PubMed  Google Scholar 

  • Sumpelmann R, Witt L, Brutt M, Osterkorn D, Koppert W, Osthaus WA (2010) Changes in acid–base, electrolyte and hemoglobin concentrations during infusion of hydroxyethyl starch 130/0.42/6: 1 in normal saline or in balanced electrolyte solution in children. Paediatr Anaesth 20(1):100–104

    Article  PubMed  Google Scholar 

  • Surviving Sepsis Campaign (SSC) (2012) International Guidelines for Management of Severe Sepsis and Septic Shock http://www.survivingsepsis.org/Guidelines/Pages/default.aspx. Zugegriffen im Juni 14

    Google Scholar 

  • Trof RJ, Sukul SP, Twisk JW, Girbes AR, Groeneveld AB (2010) Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia. Intensive Care Med 36(4):697–701

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wiesen P, Canivet JL, Ledoux D, Roediger L, Damas P (2005) Effect of hydroxyethylstarch on renal function in cardiac surgery: a large scale retrospective study. Acta Anaesthesiol Belg 56(3):257–263

    CAS  PubMed  Google Scholar 

  • Wilkes MM, Navickis RJ (2001) Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 135(3):149–164

    Article  CAS  PubMed  Google Scholar 

  • Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M (2012) Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 308(15):1566–1572

    Article  CAS  PubMed  Google Scholar 

  • Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC et al (2013) Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 309(7):678–688 [Meta-Analysis Review]

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Operative Intensivmedizin und Intermediate Care, Universitaetsklinikum Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland

    Tim-Philipp Simon

  2. Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland

    Kai Zacharowski

  3. Klinik für Operative Intensivmedizin und Intermediate Care, Universitätsklinikum Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland

    Gernot Marx

Authors
  1. Tim-Philipp Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kai Zacharowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gernot Marx
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tim-Philipp Simon .

Editor information

Editors and Affiliations

  1. Klinik für Anästhesiologie, RWTH Aachen Universitätsklinikum Aachen, Aachen, Germany

    Gernot Marx

  2. Klinik für Chirurgie, Universitätsklinikum Schleswig-Holstein Campus Lübeck, Lübeck, Germany

    Elke Muhl

  3. Dir. der Klinik fuer Anaesthesie Intensivmed. und Schmerzther., Frankfurt, Hessen, Germany

    Kai Zacharowski

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Berlin Heidelberg

About this entry

Cite this entry

Simon, TP., Zacharowski, K., Marx, G. (2015). Volumentherapie. In: Marx, G., Muhl, E., Zacharowski, K. (eds) Die Intensivmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54675-4_39-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54675-4_39-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-54675-4

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Volumentherapie
    Published:
    08 July 2023

    DOI: https://doi.org/10.1007/978-3-642-54675-4_39-2

  2. Original

    Volumentherapie
    Published:
    27 March 2015

    DOI: https://doi.org/10.1007/978-3-642-54675-4_39-1

Search

Navigation